Imsyser Eye Drops 15ml is marketed as a liquid silver eye product. Product-specific evidence establishing its ocular safety, effectiveness and finished-product sterility has not been independently verified for this page. Ask an eye-care professional before considering use.
Manufacturer-labelled formulation
The available label lists “Silver Ag+4”, “Nano Silver .01”, “Sterile Water” and “Micron 20ppm (0.0020%)”. These terms are reproduced as manufacturer-labelled information, not an independently verified chemical specification. The precise silver species, particle characteristics, meaning and units of “.01”, and concentrations of each component require clarification from the manufacturer.
The label describes the formulation as having no preservatives. Listing sterile water as an ingredient does not by itself establish that the finished product remains sterile during manufacture, storage or use.
Directions and precautions
The label states “1 Drop - 3 Times Daily”. This is a transcription of the label, not a verified dosing recommendation. Suitability, duration, use with contact lenses and use alongside other eye medicines should be confirmed with a qualified eye-care professional. No blanket assurance of suitability for children, pregnancy or all ages is made here.
The label instructs keeping the product out of reach of children and storing it in a cool, dry place. Check your supplied pack for current instructions, expiry and any after-opening discard period.
Eye drops must be sterile. Wash hands before handling eye products and avoid touching the dropper tip to your eye, skin or any surface. Do not use a damaged or compromised container. Stop use and seek medical advice if you experience pain, discharge, discomfort or changes in vision. Do not rely on this product to self-treat a suspected eye infection or delay professional assessment.
Claims and evidence limitations
This page does not claim that the product prevents or treats bacterial, viral, fungal or parasitic eye infections, reduces inflammation, restores eye health, is non-toxic or is safe for all ages. Claims of superior potency, “quantum-engineered” effects and specific silver-cluster performance have not been independently substantiated for this formulation.
The FDA cautions against unapproved eye products containing silver because of potential long-term effects, including permanent changes in eye colour. This is general safety context, not a product-specific laboratory finding or a determination of this product’s South African regulatory status.
Testing transparency
A current full specification, batch-matched certificate of analysis and independently verifiable finished-product sterility and ocular-safety reports have not yet been reviewed and linked here. Relevant documentation should identify the manufacturer, batch, laboratory, report number, methods, dates, results and acceptance criteria. Supporting evidence should address silver identity and concentration, particle characteristics, pH, osmolality, packaging integrity, stability, and maintenance of sterility after opening, including a validated discard period. A purity or silver-content report alone does not establish suitability for use in the eye.
No product-specific regulatory approval is implied. Any required disclaimer on the supplied packaging should be retained; such a disclaimer is not itself evidence of a safety problem.
Read the FDA’s eye-drop safety guidance.
